Zynex names Brown new VP of sales and marketing

Zynex names Brown new VP of sales and marketing

ENGLEWOOD -- Zynex, Inc . (NASDAQ: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac... Read More

Friday March 1, 2019 0 comments Tags: Englewood, Zynex, Christopher Brown, Thomas Sandgaard

Paragon 28 launches TenoTac soft tissue surgical foot repair system

Paragon 28 launches TenoTac soft tissue surgical foot repair system

ENGLEWOOD-- Paragon 28 announced the launch of a new foot repair system. The Paragon 28 TenoTac Soft Tissue Fixation System was designed to provide surgeons a more simplified and... Read More

Thursday February 28, 2019 0 comments Tags: Englewood, Paragon 28, TenoTac

Zynex announces uplisting to Nasdaq Capital Market

Zynex announces uplisting to Nasdaq Capital Market

ENGLEWOOD -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke... Read More

Friday February 8, 2019 0 comments Tags: Englewood, Zynex, Thomas Sandgaard

DISH to build Google Assistant into Hopper DVR

DISH to build Google Assistant into Hopper DVR

ENGLEWOOD -- DISH today announced it is building the Google Assistant into its Hopper family of receivers. In coming months, customers will be able to use the DISH voice remote to ask the... Read More

Wednesday January 9, 2019 0 comments Tags: Englewood, DISH, DISH Hopper, Niraj Desai

Sling TV brings first vMVPD to Oculus Go VR headset

Sling TV brings first vMVPD to Oculus Go VR headset

ENGLEWOOD -- Sling TV today announced it is the first virtual multichannel video programming distributor (vMVPD) to launch on Oculus Go, the all-in-one wireless virtual reality (VR) headset. ... Read More

Tuesday December 18, 2018 0 comments Tags: Englewood, Sling TV, Jimshade Chaudhari, Oculus Go

Ampio updates regulatory status for Ampion drug

Ampio updates regulatory status for Ampion drug

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it met with the FDA on Dec. 12 to discuss final guidance to achieve regulatory approval for its osteoarthritis drug Ampion.... Read More

Friday December 14, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Ampio provides update on Ampion regulatory review

Ampio provides update on Ampion regulatory review

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) reports favorable regulatory and peer-review on the status of Ampion, the companys drug for osteoarthritis of the knee. ... Read More

Tuesday November 27, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Ampio updates Ampion regulatory progress

Ampio updates Ampion regulatory progress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion... Read More

Monday November 12, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Mike Macaluso